Evidence map›Paper›PMID 29146734›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.

Minan Wang, Li-Chin Yao, Mingshan Cheng, Danying Cai, Jan Martinek, Chong-Xian Pan, Wei Shi, Ai-Hong Ma, Ralph W De Vere White, Susan Airhart and 7 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed, 2 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 2 syntheses or guidelines pooled it, 349 citations in OpenAlex.

  1. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.International journal of molecular sciences · 2021
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Humanized mouse models ofOncoimmunology · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Minan WangDepartment of In Vivo Pharmacology Services, The Jackson Laboratory, Sacramento, California, USA.
Li-Chin YaoDepartment of In Vivo Pharmacology Services, The Jackson Laboratory, Sacramento, California, USA.
Mingshan ChengDepartment of In Vivo Pharmacology Services, The Jackson Laboratory, Sacramento, California, USA.
Danying CaiDepartment of In Vivo Pharmacology Services, The Jackson Laboratory, Sacramento, California, USA.
Jan MartinekDepartment of Immunology, The Jackson Laboratory, Farmington, Connecticut, USA.
Chong-Xian PanDepartment of Urology, Davis Comprehensive Cancer Center, University of California, Davis, California, USA.
Wei ShiDepartment of Urology, Davis Comprehensive Cancer Center, University of California, Davis, California, USA.
Ai-Hong MaDepartment of Biochemistry and Molecular Medicine, Davis Comprehensive Cancer Center, University of California, Davis, Davis, California, USA.
Ralph W De Vere WhiteDepartment of Urology, Davis Comprehensive Cancer Center, University of California, Davis, California, USA.
Susan AirhartDepartment of Immunology, The Jackson Laboratory, Farmington, Connecticut, USA.
Edison T LiuDepartment of Immunology, The Jackson Laboratory, Farmington, Connecticut, USA.
Jacques BanchereauDepartment of Immunology, The Jackson Laboratory, Farmington, Connecticut, USA.
Michael A BrehmDepartment of Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Dale L GreinerDepartment of Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Leonard D ShultzDepartment of Immunology, The Jackson Laboratory, Bar Harbor, Maine, USA.
Karolina PaluckaDepartment of Immunology, The Jackson Laboratory, Farmington, Connecticut, USA.
James G KeckDepartment of In Vivo Pharmacology Services, The Jackson Laboratory, Sacramento, California, USA.
Jackson Laboratory · USUniversity of California, Davis · USUniversity of Massachusetts Chan Medical School · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Targeted-and timed-releasing nanotherapeutics against leukemia stem cellsR01CA176803 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PAN, CHONG-XIAN · 2015 to 2019
$1.8M
BLRD VA I01 BX001784BLRD VA I01 BX003840NCI NIH HHS P30 CA034196NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA176803
6 · The paper itself

Abstract

Establishment of an in vivo small animal model of human tumor and human immune system interaction would enable preclinical investigations into the mechanisms underlying cancer immunotherapy. To this end, nonobese diabetic (NOD).Cg- Prkdc

Indexed as

ImmunotherapyAnimalsAntibodies, Monoclonal, HumanizedCD8-Positive T-LymphocytesCell Line, TumorFemaleHumansImmunity, CellularMiceMice, Inbred NODNeoplasmsProgrammed Cell Death 1 ReceptorXenograft Model Antitumor AssaysAntibodies, Monoclonal, HumanizedPDCD1 protein, humanpembrolizumabProgrammed Cell Death 1 Receptorcheckpoint inhibitormouse modelpatient-derived xenograftpembrolizumab

Identifiers

PMID29146734
PMCPMC5892726
OpenAlexW2768987490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.